Hives Lasting More Than Six Weeks Are a Different Disease

One date changes the whole investigation

Someone breaks out in wheals. They think about what they ate, what they touched, what detergent they changed. That is a completely reasonable response, and for acute urticaria it is often productive — a drug, a food, an infection, an insect sting. Acute hives are a reaction, and reactions have causes worth finding.

Then the six-week mark passes and almost nobody updates the model.

Chronic spontaneous urticaria is defined by wheals, angioedema, or both, recurring most days for longer than six weeks with no identifiable external trigger. That last clause is not a description of an incomplete investigation. It is the definition. In chronic spontaneous urticaria, the mast cells in the skin are being degranulated by something internal — in a large proportion of cases by autoantibodies, either IgE directed at self-antigens or IgG directed at the IgE receptor itself. The disease is autoreactive. There is, usually, nothing out there to find.

This is the point at which a great deal of avoidable suffering happens, because the patient's instinct and the disease's biology are pointing in opposite directions. The instinct says keep hunting. The biology says the hunt is over before it started. And in the months spent on elimination diets and allergen panels, the treatment that would have worked is not being escalated.

An important qualifier: chronic urticaria does have subtypes that are inducible — triggered by cold, pressure, heat, vibration, water, exercise or sunlight — and those are real, testable and worth identifying, because the trigger is physical rather than allergic. If wheals appear reliably minutes after a specific physical stimulus, that is a different conversation. The 'spontaneous' label means precisely what it says.

Why the allergy panel comes back clean

Guidelines have moved steadily away from broad screening in this condition, and the reasoning is worth understanding rather than just accepting.

The recommended baseline workup for chronic spontaneous urticaria is deliberately minimal: a full history and examination, a complete blood count with differential, an inflammatory marker such as ESR or CRP, and thyroid function. That is close to the whole list. Extensive routine laboratory evaluation and empirical elimination diets not guided by the history are explicitly not recommended, on the grounds that they do not improve outcomes and are not cost-effective. A recent review of diagnostic testing puts the consequences of over-testing bluntly — frustration for patients and clinicians, delays in treatment, and unnecessary cost.

The key word in the guidance is 'guided'. If the history genuinely points at a specific drug or food — a consistent, reproducible temporal relationship — then testing for that thing is appropriate. What is not appropriate is a broad panel fired off in hope. A systematic review looking at skin prick test positivity to inhalant allergens in chronic spontaneous urticaria found what the biology predicts: sensitisation markers show up at rates that reflect the background population rather than explaining the disease. A positive result on a panel does not mean you have found the cause; it means you have found something the person happens to be sensitised to, which most people are.

And this is where a positive test can actively hurt. Told they react to dust mite or to a food, patients restrict, the hives continue because the restriction was irrelevant, and the conclusion drawn is usually 'I must not have restricted hard enough' rather than 'that was never the mechanism'. Elimination spirals that end in genuinely inadequate diets start exactly here.

The more useful thing to do with the time is record the disease rather than chase it. The Flare Diary tool exists for that, and a fortnight of honest daily records tells a clinician more than a broad panel will.

UAS7: how the ladder gets climbed

Chronic urticaria fluctuates enormously day to day, which makes 'how bad is it' almost impossible to answer from memory in a consultation, and makes 'is the treatment working' harder still. The Urticaria Activity Score exists to solve that, and it is simple enough to do at a kitchen table.

Each day you score two things. Wheals: 0 for none, 1 for mild (fewer than about twenty in 24 hours), 2 for moderate (roughly twenty to fifty), 3 for intense (more than fifty, or large confluent areas). Itch: 0 for none, 1 for mild and not troublesome, 2 for moderate and troublesome but not interfering with sleep or daily activity, 3 for intense, interfering with both. Add those for a daily score of 0 to 6, then sum seven consecutive days for a UAS7 between 0 and 42.

The bands are what make the number actionable. Zero is urticaria-free. One to six is well-controlled. Seven to fifteen is mild, sixteen to twenty-seven moderate, and twenty-eight to forty-two severe. Guidelines recommend UAS7 in routine practice, not just in trials, precisely because treatment decisions are supposed to be driven by it — and its validity, reliability and responsiveness have been formally assessed. A practical note from the ASSURE-CSU study: the once-daily and twice-daily versions of the score give comparable values, so the simpler once-daily version is fine.

The reason to bother is that this disease is remitting and relapsing, and human memory is dominated by the worst week. A patient who has improved from severe to mild will often report no improvement, because the bad days are still bad and those are the days they remember. A number collected daily does not have that bias, and it is the difference between escalating a treatment that is working and abandoning it. The Hives UAS7 tool will do the tally, and the Itch Scale tool is useful if itch is the dominant symptom and you want to track it separately from the wheals.

The dose most people never reach

Here is the practical fact that changes outcomes most often, and it is routinely missed because it contradicts a box of pills.

First-line treatment is a second-generation, non-sedating H1-antihistamine at standard dose. If that does not control the disease, the guideline recommendation is not to switch to something exotic — it is to increase the dose of the same class, up to fourfold the standard dose, under medical supervision. Four times what the packet says.

A great many patients never get there. They take one tablet a day for two weeks, conclude that antihistamines do not work for them, and stop. Their clinician, if not familiar with the urticaria guidance, may agree. And a treatment that would have controlled the disease at a higher dose gets written off at the starting dose — while a first-generation sedating antihistamine, which the guidelines steer away from because of the cognitive and sleep effects, gets reached for instead because it at least makes the nights survivable.

The up-dosing recommendation applies to the modern non-sedating agents specifically, and it must be done with medical guidance rather than by a person deciding to quadruple their own dose. It is a conversation to initiate, not an instruction to follow from an article.

Beyond that, the ladder continues. For patients still symptomatic on high-dose antihistamines, add-on omalizumab — an anti-IgE biologic — is the established next step, with ciclosporin as an alternative. And the field is moving: dupilumab has now been through phase 3 trials in chronic spontaneous urticaria in patients inadequately controlled on antihistamines, extending the biologic options beyond a single drug for the first time in years. Someone told a decade ago that nothing more could be done for their hives is working from an out-of-date map.

What skincare can and cannot do here

It is worth being unambiguous, because this is a site about products and the honest answer is that products are not the treatment.

Chronic spontaneous urticaria is a systemic mast-cell problem. No topical resolves it, and anything sold as a hives cream is addressing the sensation rather than the disease. What topical care can legitimately do is keep the skin comfortable and avoid making things worse, which is not nothing when the itch is the thing destroying your sleep.

The useful principles are few. Keep the skin barrier intact and unirritated with a bland, fragrance-free emollient — ↗Vanicream Moisturizing Lotion or ↗Aveeno Eczema Therapy Moisturizing Cream with ↗colloidal oatmeal are sensible, provided the expectation is comfort rather than control. Wash with something that does not strip: ↗Cetaphil Gentle Skin Cleanser over anything foaming and fragranced. Where skin is broken from scratching, plain ↗petrolatum such as ↗Vaseline Original Healing Jelly is the safest occlusive there is.

What to avoid is more specific. Heat is a near-universal aggravator of urticarial itch, which makes hot showers a bad habit here even though they feel good in the moment. And counter-irritant actives — ↗menthol and camphor — are a genuine trap: they produce a cooling sensation that reads as relief while stimulating the same sensory nerves that are already overactive, and on inflamed skin they can extend the problem. A cool compress does the same job with none of the downside.

On the antihistamine question that always comes up in an itch context, ↗whether antihistamines actually help itch has a different answer in urticaria than in eczema — here histamine is genuinely central to the mechanism, which is exactly why the dose matters so much. And if scratching has become its own problem, ↗breaking the itch-scratch cycle applies regardless of what started it.

The things that are not just hives

Four presentations sit inside or alongside chronic urticaria and are managed differently. Recognising them is the part of this subject with the highest stakes.

Individual wheals lasting more than 24 hours. Ordinary urticarial wheals are migratory — any single one appears, peaks and fades within a day, even while new ones keep arriving elsewhere. A lesion that stays put for longer than that, especially if it is painful rather than itchy or leaves a bruise or brown stain as it fades, raises the possibility of urticarial vasculitis, which is a different diagnosis and needs a biopsy rather than a higher antihistamine dose.

Swelling with no wheals at all. Angioedema accompanying hives is part of the same mast-cell picture. Angioedema occurring alone, without any wheals, points at a bradykinin-mediated mechanism instead — ACE-inhibitor-induced angioedema or hereditary angioedema. That distinction matters enormously, because bradykinin-mediated angioedema does not respond to antihistamines, steroids or adrenaline, and has its own specific treatments.

Anything involving the airway. Swelling of the tongue, lips, throat, or any difficulty breathing or swallowing is an emergency, not a dermatology appointment.

Hives with systemic features. Wheals arriving alongside vomiting, abdominal pain, dizziness, a drop in blood pressure or a feeling of impending doom, particularly shortly after an exposure, is anaphylaxis rather than urticaria, and it needs adrenaline and emergency care immediately.

Everything else — itchy, migratory wheals coming and going for months, driving you mad, resolving without a mark — is the disease this article is about. It is miserable and it is not dangerous, it has a defined treatment ladder that most people never finish climbing, and it remits spontaneously in a large share of patients given enough time. The most useful things you can bring to the appointment are a UAS7 from the last two weeks and the question of whether your antihistamine dose has actually been optimised. Those two things move more cases forward than any test.